DEFENSIN THERAPEUTICS ApS: Financial statements 2019
CVR: 35513280
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
DEFENSIN THERAPEUTICS ApS (CVR 35513280) has filed annual accounts for 2019. In 2019, the company reported a net result of DKK -1,721,113 compared with DKK -2,952,934 the year before. Equity in the 2019 report amounted to DKK 4,823,177. The solvency ratio was 95.7%. The company had 1 employee in the financial year.
- Profit/Loss
- DKK -1,721,113
- Equity
- DKK 4,823,177
- Total Assets
- DKK 5,041,681
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | - | -1.7M | 4.8M | 1 |
| 2018 | - | - | -3M | 1M | - |
| 2017 | 0 | 0 | -2M | 3.9M | - |
| 2016 | 11.1M | 11.1M | 6M | 6M | 1 |
| 2015 | - | - | -811K | -53K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
DEFENSIN THERAPEUTICS ApS has published its annual report for 2018. The net result was DKK -2,952,934.
As of April 30, 2019, Robert Ehehalt has joined the board of directors of DEFENSIN THERAPEUTICS ApS.
As of April 30, 2019, Jan Wehkamp has left the board of directors of DEFENSIN THERAPEUTICS ApS.
About DEFENSIN THERAPEUTICS ApS
DEFENSIN THERAPEUTICS ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2013. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Peter Hviid Nordkild. The board consists of Ejner Bech Jensen (chair), Matthew Alister Cooper, Peter Hviid Nordkild and Robert Ehehalt. The company's owners include NOVOZYMES A/S, PN INVESTMENT ApS and NEVE INVEST ApS. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK -538,913 and a net result of DKK -539,063 compared with DKK -130,534 the year before. Equity in the 2025 report amounted to DKK 774,437.